The authors defined whether platelet-derived growth factor, a mitogenic stimulant of vascular tissues, and Angiotensin II, a potent vasoactive peptide, could result in the activation of adenosine diphosphate ribosylation factor 6 (ARF6) in a human model of aortic smooth muscle cell.
[Scientific Reports]